Elutia Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | Outperform |
9
|
$160.40 | $178.42 | 12.22% | 11 | $283.25B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.67 | $118.92 | 20.86% | 7 | $182.09B |
| SYK | Stryker Corp | Outperform |
10
|
$330.86 | $353.16 | 13.64% | 24 | $126.04B |
| MDT | Medtronic | Outperform |
11
|
$82.76 | $92.47 | 16.00% | 9 | $109.89B |
| EW | Edwards Lifesciences Corp | Outperform |
11
|
$87.42 | $91.18 | 13.25% | 5 | $52.68B |
| 4543 | Terumo | Outperform |
18
|
¥5.63k | ¥4.97k | -9.46% | 0 | ¥3.76T |
| BAX | Baxter International Inc | Outperform |
17
|
$35.95 | $44.86 | 22.39% | 5 | $18.32B |
| SN. | Smith & Nephew | Outperform |
18
|
£10.02 | £16.09 | 62.08% | 10 | £8.73B |
| IART | Integra LifeSciences Holdings | Hold |
16
|
$25.30 | $46.60 | 0.79% | 4 | $1.82B |
| LMAT | LeMaitre Vascular | Outperform |
18
|
$76.00 | $59.86 | 1.32% | 0 | $1.45B |
| AORT | Artivion | Buy |
12
|
$23.40 | $24.15 | 10.04% | 0 | $878.83M |
| AVR | Anteris Technologies Ltd | Buy |
10
|
$21.07 | $28.00 | 42.38% | 0 | $408.99M |